March 24, 2022 – Therapy with DNA repair inhibitors in early phase clinical trials

The empty vector and KDELR-D193N-transfected cells were both double-stained for pASAP1 (pTyr 782, red) (A) or pFAK (pTyr 861, red) (B) and separately for GM130

Day: March 24, 2022

The empty vector and KDELR-D193N-transfected cells were both double-stained for pASAP1 (pTyr 782, red) (A) or pFAK (pTyr 861, red) (B) and separately for GM130 (green) or myc (green), respectively

Day: March 24, 2022

﻿The empty vector and KDELR-D193N-transfected cells were both double-stained for pASAP1 (pTyr 782, red) (A) or pFAK (pTyr 861, red) (B) and separately for GM130 (green) or myc (green), respectively

The empty vector and KDELR-D193N-transfected cells were both double-stained for pASAP1 (pTyr 782, red) (A) or pFAK (pTyr 861, red) (B) and separately for GM130 (green) or myc (green), respectively